Venezuela Sanctions Are Back on the Table

He failed to keep that promise, which has now... [Energy and Capital Header] Practical Investment Analysis for the New Energy Economy Venezuela Sanctions Are Back on the Table Keith Kohl | Apr 18, 2024 I’m convinced we live in a time loop where we’re doomed to repeat our mistakes. Today, I can’t help but feel a hefty dose of déjà vu as I scroll through this morning's headlines. It didn’t take long to come across the latest threat from the Biden administration that it would reimpose oil sanctions on Venezuela. You know, last summer I jokingly told you that insanity was doing the same thing over and over and expecting different results, and that there was a certain degree of [insanity in mending ties with Venezuela.Â]( But there was a reason why I believe President Biden waived sanctions on Venezuela — he had no choice. To understand why this is, you first have to realize that we’ve backed ourselves into a corner. Depleting more than half of the strategic reserves in 2022 to provide short-term relief for oil prices when the market was panicking over the Russia-Ukraine war was a gamble for President Biden. Couple this with flat growth in U.S. oil production in 2024, and we’ve officially handed over the keys to controlling global crude supply to OPEC and Russia. Tesla Is Dead... Elon Musk Is Ruined Thanks to a new discovery — known as “Blue Gas” — electric car companies like Tesla are about to go down in flames. “Blue Gas” is 100% emission-free, can propel vehicles hundreds of miles, and allows cars to fully charge in just minutes. And the tiny company behind it is primed to absolutely shatter any gains ever paid out by Tesla. [Click here before this stock explodes in the coming months.]( To be fair, it really was the only tool he had available at the time; we can only speculate how high crude prices would’ve climbed if it hadn’t been for the sale of 180 million barrels from the SPR. He made an executive decision, for good or for worse. Now it’s two years later, and people are finally starting to realize that we won’t be replacing those crude reserves anytime soon — especially if the goal is to purchase those barrels back below $70 per barrel. Meanwhile, backing off from our sanctions on Venezuela has yielded an embarrassing trickle of oil to help keep prices stable. Go ahead and look at our imports from Venezuela since we started buying crude last year: [venezuela oil imports] Last January, we imported approximately 152,000 barrels per day of Venezuelan crude. Remember, this is the poor quality oil that our refiners along the Gulf Coast of Mexico crave — their facilities are geared toward processing this heavy crude. Let’s ignore the fact that PDVSA, Venezuela’s state-run oil company, is in shambles. Venezuela’s production has been in jeopardy ever since output started falling off the cliff 24 years ago. Of course, also keep in mind that the ONLY stipulation we asked for from President Maduro was to simply hold free and fair elections. That’s it. That’s all he had to do to for us to keep buying their oil. [This "Limitless" Pill Could Be Bigger than Ozempic!]( This is a brand new class of medicine that could make investors an absolute FORTUNE. Now, this isn’t Ozempic... It’s called EN-23, and it’s turning traditional medicine on its head. Because instead of addressing and treating only one issue at a time like diabetes or obesity... At this very moment, scientists around the world are studying EN-23 for the treatment of: Alzheimer’s, Parkinson’s, Arthritis, Diabetes, Erectile dysfunction, Obesity, Epilepsy, Autoimmune diseases... That’s why Kevin O’Leary, Peter Thiel, and CEO of ChatGPT, Sam Altman have all invested in EN-23... And why savvy investors who act right now have the chance to grab a slice of this massive windfall. [Learn more about this life-saving treatment here.]( Even still, he failed to keep that promise, which has now put President Biden between a rock and a hard place. Over the next few days, the U.S. is going to make a decision on whether or not to reimpose sanctions on PDVSA. Some of you may have caught wind of a story regarding U.S. officials meeting secretly with President Maduro to remind him of his promises. But here’s the hard part about this decision… Putting sanctions back in place could help lead to precisely what President Biden fears most — high oil prices during an election year. It’s a case of "damned if you do, damned if you don’t" for the Biden administration. Fortunately for us, there’s a way out of this mess — [perhaps its time you take a moment and check out this opportunity for yourself.]( Until next time, [Keith Kohl Signature] Keith Kohl [[follow basic]Check us out on YouTube!](  The NEXT Albemarle?(Tiny Firm Set to Be the Second-LargestLithium Producer Is Trading for $1) North Carolina-based Albemarle is not only the largest lithium company by market cap, but it's also the #1 lithium producer in the world. Albemarle’s shares recently soared from $52 to a high of $334. That’s a staggering 542% return in just 31 months. However, I’ve discovered a little-known company in America poised to become the next Albemarle, potentially delivering even BIGGER profits to investors. This is NOT a large company like Exxon that only recently entered the lithium market. This little-known firm is building the first large-scale lithium extraction facility in America, outpacing competitors like Exxon in the race to commercial lithium production. The firm aims to produce 30,000 tons of lithium a year for the next two decades... Positioning itself behind Albermale as the world’s second-largest lithium producer. And currently, the stock is trading at right around $1 a share. [Click here to get the full story.]( [Fb]( [Li]( [Tw]( This email was sent to {EMAIL}. You can manage your subscription and get our privacy policy [here](. Energy and Capital, Copyright © 3 East Read Street, Baltimore, MD 21202. Please note: It is not our intention to send email to anyone who doesn't want it. If you're not sure why you're getting this e-letter, or no longer wish to receive it, get more info [here]( including our privacy policy and information on how to manage your subscription. If you are interested in our other publications, please call our customer service team at [1-877-303-4529](tel:/18773034529).